Trial Details
COMPLETEDBasic Information
| Clinical ID | c4371 |
|---|---|
| Identifier | NCT00615199 |
| Trial Title | A Study to Investigate the Safety and Efficacy of CP-690,550 in Patients With Moderate to Severe Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: CP-690,550|DRUG: CP-690,550|DRUG: CP-690,550|DRUG: Placebo |
Participant Information
| Sponsor | Pfizer |
|---|---|
| City | Birmingham |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2008-01 |
|---|---|
| Primary Completion Date | 2009-10 |
| Completion Date | 2009-10 |